AHA responds to the Office of Management and Budget Deregulation Request for Information.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA urges Secretary U.S. Department of Health and Human Services to reject the effort by several large drug companies to undermine the 340B Drug Pricing Program by imposing a “rebate model,”
AHA expresses support for the House Save Healthcare Workers Act (H.R. 3178).
AHA expresses support for the Senate Save Healthcare Workers Act (S. 1600).
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
AHA comments on the Centers for Medicare & Medicaid Services information collection request regarding the Medicare Transaction Facilitator (MTF) under the Medicare drug negotiation program.
The American Hospital Association (AHA) writes to express support for the Medicaid program as the reconciliation package is developed.
April 15, 2025The Honorable Kevin HernU.S. House of Representatives171 Cannon House Office BuildingWashington, DC 20515
AHA responds to the Centers for Medicare & Medicaid Services (CMS) rule on marketplace integrity and affordability.
April 4, 2025Michael Chernew, Ph.D.ChairmanMedicare Payment Advisory Commission425 I Street, NW, Suite 701Washington, D.C. 20001Dear Chairman Chernew: